Fostering a deeper understanding of COVID-19-associated mucormycosis - A commentary on "The mucormycosis coinfection in the context of global COVID-19 outbreak: A fatal addition to the pandemic spectrum" (Int. J. Surg. 2021:106031).

MohanaSundaram, ArunSundar; Sathanantham, Shanmugarajan Thukani; Chinchole, Vijay; Patil, Bhushan; Velayutham, Ravichandiran

MohanaSundaram, ArunSundar; Sathanantham, Shanmugarajan Thukani; Chinchole, Vijay; Patil, Bhushan; Velayutham, Ravichandiran.

Affiliation

MohanaSundaram A; School of Pharmacy, Sathyabama Institute of Science and Technology, Chennai, Tamilnadu, India School of Pharmaceutical Sciences, Vels Institute of Science, Technology and Advanced Studies (VISTAS), Chennai, Tamilnadu, India Manobal Neuropsychiatric Clinic, Dombivli, Maharashtra, India MannSparsh Neuropsychiatric Hospital, Kalyan, Maharashtra, India Manasa Rehabilitation & De-Addiction Center, Titwala, Maharashtra, India National Institute of Pharmaceutical Education and Research (NIPER), Kol

Int J Surg ; 94: 106110, 2021 10.

Article in En | MEDLINE | ID: mdl-34534704

Subject(s)

COVID-19; Coinfection; Mucormycosis; Disease Outbreaks; Humans; Mucormycosis/diagnosis; Mucormycosis/epidemiology; Pandemics; SARS-CoV-2

Key words

Breakthrough infection; COVID-19; Early diagnosis; Mucormycosis; Psychiatric support; Recurrence

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Coinfection / COVID-19 / Mucormycosis Type of study: Diagnostic_studies / Risk_factors_studies / Screening_studies Limits: Humans Language: En Journal: Int J Surg Year: 2021 Document type: Article Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google